Nanobiotix (NBTX) Other Accumulated Expenses (2020 - 2025)

Nanobiotix's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $7.9 million for Q2 2025.

• On a quarterly basis, Other Accumulated Expenses rose 1.2% year-over-year to $7.9 million in Q2 2025; TTM through Jun 2025 was $7.9 million, a 1.2% increase from a year earlier, with the FY2024 full-year figure at $8.1 million, down 1.78% from the prior year.
• Other Accumulated Expenses declined to $7.9 million in Q2 2025 per NBTX's latest filing, from $8.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $8.2 million in Q4 2023 and bottomed at $6.3 million in Q4 2021.
• The 5-year median for Other Accumulated Expenses is $7.8 million (2024), against an average of $7.4 million.
• Across the five-year window, Other Accumulated Expenses retreated 24.43% in 2021 and climbed 18.52% in 2022, its largest moves.
• Year by year, Other Accumulated Expenses stood at $6.3 million in 2021, then increased by 10.53% to $7.0 million in 2022, then rose by 17.34% to $8.2 million in 2023, then slipped by 1.78% to $8.1 million in 2024, then fell by 1.7% to $7.9 million in 2025.
• Per Business Quant, the three latest NBTX Other Accumulated Expenses figures stand at $7.9 million (Q2 2025), $8.1 million (Q4 2024), and $7.8 million (Q2 2024).